International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-5 doi: https://doi.org/10.5281/zenodo.13865301
Original Research Article
Multidetector Computed Tomography and Ultrasound Role in Evaluation of Focal Hepatic Lesions with Pathological Correlation
Published
Oct. 29, 2024
Abstract

Introduction:This study aims to determine the role of USG and MDCT with pathological correlation in evaluation of focal hepatic lesions in arriving at a specific diagnosis before surgery.Material and Methods:A total number of 30 patients with liver lesions who were referred to Department of Radiodiagnosis, SSIMS & RC, Davanagere.Results:Correlation of ultrasound diagnosis with histopathology.The sensitivity of diagnosing cholangiocarcinoma is 50%, abscess is 85.71 and HCC is 80%. Whereas for FNH, Metastasis and hydatid cyst it was 100%. The specificity for all the focal hepatic lesions mentioned was 100% except for metastasis which was 77.7%.Correlation of CT diagnosis with histopathology: The sensitivity of diagnosing abscess is 71.42%. Whereas for all other FLL it was 100%. The specificity for all the focal hepatic lesions mentioned was 100% except for metastasis which was 94.4%, HCC was 96%.Conclusion: Contrast enhanced computed tomography with ultrasonography and histopathological correlation is a sensitive tool for diagnosing focal hepatic lesions and differentiating between benign and malignant lesions with high accuracy

Recommended Articles
Loading Image...
Volume-5, Issue-5
Citations
2545 Views
415 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved